Romeu Gema, Marzullo-Zucchet Leopoldo José, Díaz Javier, Villarroya Sara, Budía Alberto, Ordaz Domingo de Guzmán, Caballer Vicent, Vivas David
Urology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
Centro de Investigación en Economía y Gestión de la Salud (CIEGS), Universitat Politècnica de València, Valencia, Spain.
World J Urol. 2021 Sep;39(9):3593-3598. doi: 10.1007/s00345-021-03620-w. Epub 2021 Feb 22.
To analyze the efficiency and cost-utility profile of ureteroscopy versus shock wave lithotripsy for treatment of reno-ureteral stones smaller than 2 cm.
Patients treated for urinary stones smaller than 2 cm were included in this study (n = 750) and divided into two groups based on technique of treatment. To assess the cost-utility profile a sample of 48 patients (50% of each group) was evaluated. Quality of life survey (Euroqol 5QD-3L) before-after treatment was applied, Markov model was designed to calculate quality of life in each status of the patients (stone or stone-free with and without double-J stent) and to estimate the incremental cost-utility. Monte carlo simulation was conducted for a probabilistic sensitivity analysis. Chi-square was used for comparing qualitative variables and T student's for continuous variables.
Shock wave lithotripsy group had 408 (54.4%) and ureteroscopy group had 342 (45.6%) patients. Of them, 56.3% were treated for renal stones and 43.7% for ureteral stones. Ureteroscopy produced slightly higher overall quality of patients' life, but produced a significant higher overall cost per quality-adjusted life year (QALY) than shock wave lithotripsy, exceeding the cost-utility threshold (20,000€/QALY). Sensitivity analysis confirmed results in 93.65% of cases. Difference was maintained in subgroup analysis (ureteral vs renal stones).
Results suggest that in our clinical setting shock wave lithotripsy has better cost-utility profile than ureteroscopy for treatment of reno-ureteral stones less than 2 cm, but excluding waiting times, in ideal clinical setting, ureteroscopy would have better cost-utility profile than shock wave lithotripsy.
分析输尿管镜检查与冲击波碎石术治疗小于2厘米的肾输尿管结石的效率和成本效益情况。
本研究纳入了治疗小于2厘米尿路结石的患者(n = 750),并根据治疗技术将其分为两组。为评估成本效益情况,对48例患者(每组50%)进行了评估。应用治疗前后的生活质量调查(欧洲五维健康量表5QD - 3L),设计马尔可夫模型来计算患者每种状态(有结石或无结石,有无双J支架)下的生活质量,并估计增量成本效益。进行蒙特卡洛模拟以进行概率敏感性分析。采用卡方检验比较定性变量,采用t检验比较连续变量。
冲击波碎石术组有408例患者(54.4%),输尿管镜检查组有342例患者(45.6%)。其中,56.3%的患者接受肾结石治疗,43.7%的患者接受输尿管结石治疗。输尿管镜检查使患者的总体生活质量略高,但每质量调整生命年(QALY)的总体成本显著高于冲击波碎石术,超过了成本效益阈值(20,000€/QALY)。敏感性分析在93.65%的病例中证实了结果。亚组分析(输尿管结石与肾结石)中差异依然存在。
结果表明,在我们的临床环境中,对于治疗小于2厘米的肾输尿管结石,冲击波碎石术比输尿管镜检查具有更好的成本效益情况,但不包括等待时间,在理想的临床环境中,输尿管镜检查的成本效益情况将优于冲击波碎石术。